Gorlach Jorn 5
5 · PARALLAX HEALTH SCIENCES, INC. · Filed Jan 28, 2019
Insider Transaction Report
Form 5
Gorlach Jorn
Director10% Owner
Transactions
- Award
PREFERRED STOCK (SERIES B)
2017-01-23$5.00/sh+30,000$150,000→ 393,393 total(indirect: By Hamburg Investment Co)Exercise: $0.25From: 2017-01-23Exp: 2019-01-23→ COMMON STOCK (600,000 underlying) - Award
WARRANTS (PREFERRED SERIES B)
2017-01-23+15,000→ 408,393 total(indirect: By Hamburg Investment Co)Exercise: $0.75From: 2017-01-23Exp: 2019-01-23→ COMMON STOCK (300,000 underlying)
Footnotes (1)
- [F1]Pursuant to Conversion Rights, holders of Series B Convertible Preferred Stock may elect to convert their shares at the then Conversion Ratio at any time in whole or in part for a period of two years from the date of purchase.